Biologic therapy targeting IL-17 ameliorates a case of congenital ichthyosiform cornification disorder

2018 ◽  
Vol 17 (1) ◽  
pp. 70-72 ◽  
Author(s):  
Daniela Haiges ◽  
Judith Fischer ◽  
Steffen Hörer ◽  
Cristina Has ◽  
Christoph M. Schempp
Keyword(s):  
Biologic Therapy ◽  
Cornification Disorder

Assuming cost is not an issue, should every patient with RA receive biologic therapy?

2005 ◽  
Vol 38 (19) ◽  
pp. 13
Author(s):  
Philip G. Conaghan ◽  
Eric M. Ruderman
Keyword(s):  
Biologic Therapy

Biologic therapy-related demyelinating peripheral neuropathy in a child with juvenile idiopathic arthritis

2018 ◽  
pp. 1-2
Keyword(s):  
Juvenile Idiopathic Arthritis ◽  
Peripheral Neuropathy ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Biologic Therapy ◽  
Tnf Inhibitor ◽  
Neurological Sequelae ◽  
Demyelinating Peripheral Neuropathy ◽  
Necrosis Factor ◽  
Clinical Worsening

Demyelinating peripheral neuropathy has been described in association with tumor necrosis factor (TNF) inhibitors. It is rarely developed after treatment discontinuation. We present the case of a child with juvenile idiopathic arthritis who developed peripheral neuropathy few months after TNF inhibitor withdrawal with clinical worsening of the neurological sequelae while undergoing treatment with abatacept.

Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways

2018 ◽  
Vol 18 (12) ◽  
pp. 964-978 ◽  
Author(s):  
Elisa Molinelli ◽  
Anna Campanati ◽  
Valerio Brisigotti ◽  
Annamaria Offidani
Keyword(s):  
Biologic Therapy ◽  
Efficacy And Safety ◽  
New Treatment ◽  
Treatment Targeting

Biologic therapy for uveitis: addressing access issues is paramount

2020 ◽  
Vol 50 (4) ◽  
pp. 508-509 ◽  
Author(s):  
Philip C. Robinson ◽  
Diana Conrad
Keyword(s):  
Biologic Therapy
Sign in / Sign up

Export Citation Format

Share Document